Immunovia Interim Report, January-June 2018

STOCKHOLM, Aug. 24, 2018 /PRNewswire/ — “On 3 April, trading in Immunovia’s shares started on NASDAQ Stockholm’s main market, where we are listed in the Mid Cap segment. During the second quarter we also completed a directed share issue worth around SEK 324 million to reputable…

Source: https://www.prnewswire.com:443/news-releases/immunovia-interim-report-january-june-2018-300701986.html

About the Author

has written 39592 stories on this site.

Copyright © 2010 Business and Corporate News.